pancreas cancer research program banner

Current Clinical Research Studies

Molecular Classification of Cancer
In this study, tissue, blood, or urine from people with and without cancer are collected and compared to help understand, treat, and prevent cancer.

More precise classification can help make cancer screening, detection, and treatment more effective. In April 2004, Huntsman Cancer Institute (HCI) began this tissue collection study to assist in profiling and classifying various cancers. The tissue samples are stored and administered by the Tissue Resource and Applications Core (TRAC) shared resource at Huntsman Cancer Institute (HCI), for use in ongoing and future cancer research projects.

Who is eligible to participate?
Anyone over 18 years of age can participate. Those who participate in this study consent to allow blood, urine, and/or tissue sample collection and storage. Family members and friends, as well as patients, can contribute blood and urine samples. (Not all sample types will be collected, depending on the disease being studied.) Samples from healthy individuals provide normal specimens to which diseased tissues can be compared. Researchers also need samples from patients with other diseases. For pancreas cancer research, samples are also needed from people who have other gastrointestinal cancers or pancreatitis. Scientists compare these samples to pancreas cancer tissue samples and search for the unique characteristics of pancreas cancer cells.

How are samples collected?
During regular clinic visits, technicians take blood samples for the study from participating patients at the same time they draw blood for clinical tests. Participating patients can also consent to have samples of tissues removed during their clinical treatment procedures saved for research. The consent to save tissue does not change the clinical procedure in any way. Each consent for tissue collection applies to only one procedure or surgery, so patients who have multiple procedures may be invited to participate more than once. Participants who do not have scheduled clinic visits can use the contact numbers below to schedule a blood draw.

Cancer Genetics Study
A resource for patients, families, health professionals and researchers, the Cancer Genetics Study (CGS) helps identify and recruit people who may be at higher risk for cancer because of inherited genetic factors. The CGS collects medical and family histories, blood or saliva samples, and samples of cancer tumors and precancerous lesions from participants. This study consolidates several established high-risk cancer studies at HCI. For more information about the Cancer Genetics Study, please contact the study coordinator, Bella Johnson, at 801-585-7343 or at bella.johnson@hci.utah.edu.

Quality of Life Assessment of Cancer Patients
This in-clinic review evaluates quality of life and how different treatments affect it in patients at various stages of pancreas cancer. Information is collected through questionnaires completed during clinic visits.

For more information about participating in any of the studies above, contact the Pancreas Cancer Research Program clinical research coordinator at 801-585-6049 or 1-866-809-3799 toll free.

Learn more about clinical trials at HCI

Current Pancreas Cancer Clinical Trials

Gastrointestinal cancers include cancer of the esophagus, stomach, liver, gall bladder, pancreas, small bowel, colon, appendix, and rectum. Check individual trial listings for those applying to pancreas cancer.

 

Pancreas Cancer Research Program ~ Phone: 801-585-6048